Mitral valve prolapse in systemic lupus erythematosus

F. Barzizza, A. Venco, A. M. Grandi, G. Finardi

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Despite a low incidence of clinical manifestations, autopsy data suggest endocardial and myocardial disease in about 50% of patients with systemic lupus erythematosus. To investigate whether mitral valve prolapse can be considered a clinical manifestation of cardiac involvement in systemic lupus erythematosus, we carried out an echocardiographic study in 51 affected subjects and 102 normals matched for age and sex. Prevalence of mitral valve prolapse was 25% in patients with systemic lupus erythematosus and 9% in healthy controls with a statistically significant difference (p

Original languageEnglish
Pages (from-to)59-62
Number of pages4
JournalClinical and Experimental Rheumatology
Volume5
Issue number1
Publication statusPublished - 1987

Fingerprint

Mitral Valve Prolapse
Systemic Lupus Erythematosus
Cardiomyopathies
Autopsy
Incidence

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Mitral valve prolapse in systemic lupus erythematosus. / Barzizza, F.; Venco, A.; Grandi, A. M.; Finardi, G.

In: Clinical and Experimental Rheumatology, Vol. 5, No. 1, 1987, p. 59-62.

Research output: Contribution to journalArticle

Barzizza, F, Venco, A, Grandi, AM & Finardi, G 1987, 'Mitral valve prolapse in systemic lupus erythematosus', Clinical and Experimental Rheumatology, vol. 5, no. 1, pp. 59-62.
Barzizza, F. ; Venco, A. ; Grandi, A. M. ; Finardi, G. / Mitral valve prolapse in systemic lupus erythematosus. In: Clinical and Experimental Rheumatology. 1987 ; Vol. 5, No. 1. pp. 59-62.
@article{38b59554795040a9b69216e5af69c5e2,
title = "Mitral valve prolapse in systemic lupus erythematosus",
abstract = "Despite a low incidence of clinical manifestations, autopsy data suggest endocardial and myocardial disease in about 50{\%} of patients with systemic lupus erythematosus. To investigate whether mitral valve prolapse can be considered a clinical manifestation of cardiac involvement in systemic lupus erythematosus, we carried out an echocardiographic study in 51 affected subjects and 102 normals matched for age and sex. Prevalence of mitral valve prolapse was 25{\%} in patients with systemic lupus erythematosus and 9{\%} in healthy controls with a statistically significant difference (p",
author = "F. Barzizza and A. Venco and Grandi, {A. M.} and G. Finardi",
year = "1987",
language = "English",
volume = "5",
pages = "59--62",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "1",

}

TY - JOUR

T1 - Mitral valve prolapse in systemic lupus erythematosus

AU - Barzizza, F.

AU - Venco, A.

AU - Grandi, A. M.

AU - Finardi, G.

PY - 1987

Y1 - 1987

N2 - Despite a low incidence of clinical manifestations, autopsy data suggest endocardial and myocardial disease in about 50% of patients with systemic lupus erythematosus. To investigate whether mitral valve prolapse can be considered a clinical manifestation of cardiac involvement in systemic lupus erythematosus, we carried out an echocardiographic study in 51 affected subjects and 102 normals matched for age and sex. Prevalence of mitral valve prolapse was 25% in patients with systemic lupus erythematosus and 9% in healthy controls with a statistically significant difference (p

AB - Despite a low incidence of clinical manifestations, autopsy data suggest endocardial and myocardial disease in about 50% of patients with systemic lupus erythematosus. To investigate whether mitral valve prolapse can be considered a clinical manifestation of cardiac involvement in systemic lupus erythematosus, we carried out an echocardiographic study in 51 affected subjects and 102 normals matched for age and sex. Prevalence of mitral valve prolapse was 25% in patients with systemic lupus erythematosus and 9% in healthy controls with a statistically significant difference (p

UR - http://www.scopus.com/inward/record.url?scp=0023204371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023204371&partnerID=8YFLogxK

M3 - Article

C2 - 3594966

AN - SCOPUS:0023204371

VL - 5

SP - 59

EP - 62

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 1

ER -